ACTIVE

Berro Pharma Consulting

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result
83 k €
+63,2 %over 1 year
Gross margin
120,6 k €
+49,4 %over 1 year
Equity
176,8 k €
+88,5 %over 1 year

Identity

Source · BCE/KBO

Berro Pharma Consulting is a Private limited company incorporated in 2023. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Etterbeek.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0801.395.687
Incorporation
03/05/2023
Legal form
Private limited company
Registered office
Avenue de Tervueren 112 box b7
1040 Etterbeek · BruxellesSee on map
Contributed capital
4 000,00 €
Latest accounts
31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 3 filings

Trend over 3 financial years

202520242023
Income statement
Gross margin120,6 k €80,7 k €57,2 k €
EBITDA115,6 k €71,6 k €55,6 k €
Operating result114,9 k €70,8 k €55,6 k €
Net result83 k €50,9 k €38,9 k €
Balance sheet
Equity176,8 k €93,8 k €42,9 k €
Total assets226,3 k €124,4 k €65,7 k €
Cash89,7 k €34 k €9,5 k €
Debts49,5 k €30,7 k €22,8 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

Ammar Berro

Mandate

Active

Other companies at this address

Avenue de Tervueren 112 1040 Etterbeek
CompanyCBE no.
ARECA● Active
0429.487.096
Association des Copropriétaires de l'immeuble sis à Etterbeek, avenue de Tervueren 112● Active
0895.426.893
ECOUTE 112● Active
0822.858.819

Full financial information

Source · NBB
202520242023
Type of accountMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202403/04/2023
Closing of the financial year31/12/202531/12/202431/12/2023
Length of the financial year12 months12 months9 months
Filing date04/05/202629/08/202530/08/2024
General meeting04/05/202620/08/202530/07/2024
Currency of the financial yearEUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 3 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202504/05/202604/05/2026FrenchPDF
Micro model31/12/202420/08/202529/08/2025FrenchPDF
Micro model31/12/202330/07/202430/08/2024FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

Ammar Berro

Mandate

Active

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other05/05/2023
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202583 k €↑
  2. 2024
    Annual accounts 202450,9 k €↑
  3. 2023
    Annual accounts 202338,9 k €
  4. 03/05/2023
    IncorporationPrivate limited company